lobbying_activities: 1145043

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1145043	5d0d2636-3759-469e-9a9c-e1cc1e24ce38	Q3	MEHLMAN CONSULTING, INC.	284950	ASTRAZENECA PHARMACEUTICALS	2011	third_quarter	HCR	Health care reform: implementation issues, including pharmaceutical taxes, Medicaid changes, and comparative effectiveness. H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act. Prescription Drug User Fee Act (PDUFA)	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2011-10-05T15:37:05.503000-04:00